These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11916745)

  • 21. [Urology: sperm production and prostate reduction].
    Böhlen D; Hochreiter WW; Thalmann GN; Danuser HJ
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):38-41. PubMed ID: 9491470
    [No Abstract]   [Full Text] [Related]  

  • 22. Antioxidant agents in the prevention of hepatocellular carcinoma.
    Moreno-Otero R; Trapero-Marugan M
    Eur J Cancer Prev; 2012 Jul; 21(4):323-5. PubMed ID: 22044850
    [No Abstract]   [Full Text] [Related]  

  • 23. [Formation of recurrence and carcinoma following surgical removal of prostatic adenoma].
    Gödde S; Dietz H
    Z Urol Nephrol; 1974 Mar; 67(3):175-80. PubMed ID: 4136363
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of hormonal factors in the pathogenesis of prostatic hypertrophy].
    Baranowska B; Migdalska B; Szymanowski J; Kozłowicz I
    Pol Tyg Lek; 1977 Feb; 32(6):251-3. PubMed ID: 65771
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative pathology of benign prostatic hyperplasia and prostate cancer.
    Maini A; Archer C; Wang CY; Haas GP
    In Vivo; 1997; 11(4):293-9. PubMed ID: 9292295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal signaling in prostatic hyperplasia and neoplasia.
    Marcelli M; Cunningham GR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3463-8. PubMed ID: 10522981
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of oxidative stress in prostate cancer.
    Gupta-Elera G; Garrett AR; Robison RA; O'Neill KL
    Eur J Cancer Prev; 2012 Mar; 21(2):155-62. PubMed ID: 21857523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-mesenchymal transition in prostatic disease.
    Broster SA; Kyprianou N
    Future Oncol; 2015; 11(23):3197-206. PubMed ID: 26551285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.
    Fritschi L; Glass DC; Tabrizi JS; Leavy JE; Ambrosini GL
    Occup Environ Med; 2007 Jan; 64(1):60-5. PubMed ID: 17018583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of various factors in the occurrence of prostatic cancer].
    Chaklin AV; Plotnikov SV
    Urol Nefrol (Mosk); 1984; (4):46-51. PubMed ID: 6206634
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prostatic hypertrophy as an example of a true disposition with age].
    Schinz HR; Reich T
    Acta Iber Radiol Cancerol; 1966; 21(77):259-65. PubMed ID: 4171544
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in regeneration of the prostate after cryoprostatectomy, fulguration and excision.
    Feminell JG; Tomashefsky P; Tannenbaum M; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1970; 62():25-9. PubMed ID: 4099483
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia.
    Stepanova L; Yang G; DeMayo F; Wheeler TM; Finegold M; Thompson TC; Harper JW
    Oncogene; 2000 Apr; 19(18):2186-93. PubMed ID: 10822368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostate cancer--incidence and risk factors].
    Brasso K
    Ugeskr Laeger; 2007 May; 169(20):1883-6. PubMed ID: 17553361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progresses in the study of urologic surgery in China, 1997].
    Guo Y
    Zhonghua Yi Xue Za Zhi; 1997 Dec; 77(12):912-3. PubMed ID: 9772561
    [No Abstract]   [Full Text] [Related]  

  • 37. Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia.
    Negri E; Pelucchi C; Talamini R; Montella M; Gallus S; Bosetti C; Franceschi S; La Vecchia C
    Int J Cancer; 2005 Apr; 114(4):648-52. PubMed ID: 15578689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER].
    Kogan MI; Chernogubova EA; Chibichjan MB; Macionis AJ; Povilajtite PJ; Matishov DG
    Urologiia; 2015; (3):50-4. PubMed ID: 26390560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.
    Meeker AK
    Urol Oncol; 2006; 24(2):122-30. PubMed ID: 16520276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological alterations in the prostates of Mongolian gerbils exposed to a high-fat diet and di-n-butyl phthalate individually or in combination.
    de Jesus MM; Negrin AC; Taboga SR; Pinto-Fochi ME; Góes RM
    Reprod Toxicol; 2015 Apr; 52():26-39. PubMed ID: 25697569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.